{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T20:28:32Z","timestamp":1790022512765,"version":"4.0.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T00:00:00Z","timestamp":1757289600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T00:00:00Z","timestamp":1757289600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100005153","name":"China National Funds for Distinguished Young Scientists","doi-asserted-by":"publisher","award":["82125016"],"award-info":[{"award-number":["82125016"]}],"id":[{"id":"10.13039\/501100005153","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010903","name":"National Science Foundation of China | Key Programme","doi-asserted-by":"publisher","award":["82230061"],"award-info":[{"award-number":["82230061"]}],"id":[{"id":"10.13039\/501100010903","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Immunol"],"DOI":"10.1038\/s41423-025-01344-0","type":"journal-article","created":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T09:41:44Z","timestamp":1757410904000},"page":"1398-1413","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Intestinal taurine acts as a novel immunometabolic modulator of IBD by degrading redundant mitochondrial RNA"],"prefix":"10.1038","volume":"22","author":[{"given":"Le-xi","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-huan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie-yu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-ping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-tao","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling-jie","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao-tian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang-yan","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-min","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shicheng","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-yuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7938-7532","authenticated-orcid":false,"given":"Qian","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7887-5972","authenticated-orcid":false,"given":"Jin","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,8]]},"reference":[{"key":"1344_CR1","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nature10209","volume":"474","author":"B Khor","year":"2011","unstructured":"Khor B, Gardet A, Xavier RJ. Genetics and pathogenesis of inflammatory bowel disease. Nature. 2011;474:307\u201317.","journal-title":"Nature."},{"key":"1344_CR2","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1038\/nrgastro.2014.170","volume":"11","author":"J-F Colombel","year":"2014","unstructured":"Colombel J-F. IBD\u2014genes, bacteria and new therapeutic strategies. Nat Rev Gastroenterol Hepatol. 2014;11:652\u20134.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1344_CR3","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.3390\/ijms24021526","volume":"24","author":"A Saez","year":"2023","unstructured":"Saez A, Herrero-Fernandez B, Gomez-Bris R, S\u00e1nchez-Martinez H, Gonzalez-Granado JM. Pathophysiology of inflammatory bowel disease: innate immune system. Int J Mol Sci. 2023;24:1526.","journal-title":"Int J Mol Sci"},{"key":"1344_CR4","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1097\/MIB.0000000000000955","volume":"23","author":"MC Choy","year":"2016","unstructured":"Choy MC, Visvanathan K, De Cruz P. An overview of the innate and adaptive immune system in inflammatory bowel disease. Inflamm Bowel Dis. 2016;23:2\u201313.","journal-title":"Inflamm Bowel Dis"},{"key":"1344_CR5","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/s41575-023-00769-0","volume":"20","author":"LM Hegarty","year":"2023","unstructured":"Hegarty LM, Jones G-R, Bain CC. Macrophages in intestinal homeostasis and inflammatory bowel disease. Nat Rev Gastroenterol Hepatol. 2023;20:538\u201353.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1344_CR6","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/s41575-019-0172-4","volume":"16","author":"YR Na","year":"2019","unstructured":"Na YR, Stakenborg M, Seok SH, Matteoli G. Macrophages in intestinal inflammation and resolution: a potential therapeutic target in IBD. Nat Rev Gastroenterol Hepatol. 2019;16:531\u201343.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1344_CR7","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/nrgastro.2017.136","volume":"15","author":"AN Ananthakrishnan","year":"2018","unstructured":"Ananthakrishnan AN, Bernstein CN, Iliopoulos D, Macpherson A, Neurath MF, Ali RAR, et al. Environmental triggers in IBD: a review of progress and evidence. Nat Rev Gastroenterol Hepatol. 2018;15:39\u201349.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1344_CR8","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41575-019-0258-z","volume":"17","author":"A Lavelle","year":"2020","unstructured":"Lavelle A, Sokol H. Gut microbiota-derived metabolites as key actors in inflammatory bowel disease. Nat Rev Gastroenterol Hepatol. 2020;17:223\u201337.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1344_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-43211-4","volume":"14","author":"NT Van","year":"2023","unstructured":"Van NT, Zhang K, Wigmore RM, Kennedy AI, DaSilva CR, Huang J, et al. Dietary L-tryptophan consumption determines the number of colonic regulatory T cells and susceptibility to colitis via GPR15. Nat Commun. 2023;14:7363.","journal-title":"Nat Commun"},{"key":"1344_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-021-02175-2","volume":"18","author":"LM Chen","year":"2021","unstructured":"Chen LM, Bao CH, Wu Y, Liang SH, Wang D, Wu LY, et al. Tryptophan\u2013kynurenine metabolism: a link between the gut and brain for depression in inflammatory bowel disease. J Neuroinflammation. 2021;18:135.","journal-title":"J Neuroinflammation"},{"key":"1344_CR11","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1136\/gutjnl-2022-327337","volume":"72","author":"C Michaudel","year":"2023","unstructured":"Michaudel C, Danne C, Agus A, Magniez A, Aucouturier A, Spatz M, et al. Rewiring the altered tryptophan metabolism as a novel therapeutic strategy in inflammatory bowel diseases. Gut. 2023;72:1296\u2013307.","journal-title":"Gut"},{"key":"1344_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17750-z","volume":"11","author":"LF Campesato","year":"2020","unstructured":"Campesato LF, Budhu S, Tchaicha J, Weng CH, Gigoux M, Cohen IJ, et al. Blockade of the AHR restricts a Treg\u2013macrophage suppressive axis induced by L-kynurenine. Nat Commun. 2020;11:4011.","journal-title":"Nat Commun"},{"key":"1344_CR13","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/j.jcmgh.2021.05.018","volume":"12","author":"X Zhang","year":"2021","unstructured":"Zhang X, Liu X, Zhou W, Du Q, Yang M, Ding Y, et al. Blockade of IDO\u2013kynurenine\u2013AhR axis ameliorated colitis-associated colon cancer via inhibiting immune tolerance. Cell Mol Gastroenterol Hepatol. 2021;12:1179\u201399.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"1344_CR14","doi-asserted-by":"publisher","first-page":"1279172","DOI":"10.3389\/fcimb.2023.1279172","volume":"13","author":"JJ Hou","year":"2023","unstructured":"Hou JJ, Ma AH, Qin YH. Activation of the aryl hydrocarbon receptor in inflammatory bowel disease: insights from gut microbiota. Front Cell Infect Microbiol. 2023;13:1279172.","journal-title":"Front Cell Infect Microbiol"},{"key":"1344_CR15","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1016\/j.immuni.2024.06.010","volume":"57","author":"O Perdijk","year":"2024","unstructured":"Perdijk O, Verheijden KA, van Neerven RJ, Garssen J, Kraneveld AD, Folkerts G, et al. Antibiotic-driven dysbiosis in early life disrupts indole-3-propionic acid production and exacerbates allergic airway inflammation in adulthood. Immunity. 2024;57:1939\u201354.e7.","journal-title":"Immunity"},{"key":"1344_CR16","first-page":"1","volume":"51","author":"ZH Zhao","year":"2019","unstructured":"Zhao ZH, Xin FZ, Zhou D, Xue YQ, Liu XL, Yang RX, et al. Indole-3-propionic acid inhibits gut dysbiosis and endotoxin leakage to attenuate steatohepatitis in rats. Exp Mol Med. 2019;51:1\u201314.","journal-title":"Exp Mol Med"},{"key":"1344_CR17","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/j.ajpath.2018.01.011","volume":"188","author":"EE Alexeev","year":"2018","unstructured":"Alexeev EE, Lanis JM, Kao DJ, Campbell EL, Kelly CJ, Battista KD, et al. Microbiota-derived indole metabolites promote human and murine intestinal homeostasis through regulation of interleukin-10 receptor. Am J Pathol. 2018;188:1183\u201394.","journal-title":"Am J Pathol"},{"key":"1344_CR18","first-page":"2673","volume":"18","author":"H Ripps","year":"2012","unstructured":"Ripps H, Shen W. Review: taurine: a \u201cvery essential\u201d amino acid. Mol Vis. 2012;18:2673\u201386.","journal-title":"Mol Vis"},{"key":"1344_CR19","doi-asserted-by":"publisher","first-page":"225","DOI":"10.4062\/biomolther.2017.251","volume":"26","author":"S Schaffer","year":"2018","unstructured":"Schaffer S, Kim HW. Effects and mechanisms of taurine as a therapeutic agent. Biomol Ther. 2018;26:225\u201341.","journal-title":"Biomol Ther"},{"key":"1344_CR20","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1023\/B:NERE.0000010438.40376.c9","volume":"29","author":"MH Stipanuk","year":"2004","unstructured":"Stipanuk MH. Role of the liver in regulation of body cysteine and taurine levels: a brief review. Neurochem Res. 2004;29:105\u201310.","journal-title":"Neurochem Res"},{"key":"1344_CR21","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s00726-012-1381-0","volume":"46","author":"T Miyazaki","year":"2014","unstructured":"Miyazaki T, Matsuzaki Y. Taurine and liver diseases: a focus on the heterogeneous protective properties of taurine. Amino Acids. 2014;46:101\u201310.","journal-title":"Amino Acids"},{"key":"1344_CR22","doi-asserted-by":"publisher","first-page":"116584","DOI":"10.1016\/j.lfs.2019.116584","volume":"231","author":"C Chen","year":"2019","unstructured":"Chen C, Xia S, He J, Lu G, Xie Z, Han H. Roles of taurine in cognitive function of physiology, pathologies and toxication. Life Sci. 2019;231:116584.","journal-title":"Life Sci"},{"key":"1344_CR23","doi-asserted-by":"crossref","unstructured":"El Idrissi, A Taurine Regulation of Neuroendocrine Function. In: Hu, J, Piao, F, Schaffer, SW, El Idrissi, A & Wu, J-Y, editors. Taurine 11; 2019 2019\/\/; Singapore: Springer Singapore; 2019. p. 977-85.","DOI":"10.1007\/978-981-13-8023-5_81"},{"key":"1344_CR24","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.3390\/antiox10121876","volume":"10","author":"PF Surai","year":"2021","unstructured":"Surai PF, Earle-Payne K, Kidd MT. Taurine as a natural antioxidant: from direct antioxidant effects to protective action in various toxicological models. Antioxidants (Basel). 2021;10:1876.","journal-title":"Antioxidants (Basel)"},{"key":"1344_CR25","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1007\/s00726-011-0962-7","volume":"42","author":"CJ Jong","year":"2012","unstructured":"Jong CJ, Azuma J, Schaffer S. Mechanism underlying the antioxidant activity of taurine: prevention of mitochondrial oxidant production. Amino Acids. 2012;42:2223\u201332.","journal-title":"Amino Acids"},{"key":"1344_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-015-0610-1","volume":"13","author":"A De Luca","year":"2015","unstructured":"De Luca A, Pierno S, Camerino DC. Taurine: the appeal of a safe amino acid for skeletal muscle disorders. J Transl Med. 2015;13:243.","journal-title":"J Transl Med"},{"key":"1344_CR27","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.3390\/nu15081843","volume":"15","author":"H Duan","year":"2023","unstructured":"Duan H, Song W, Guo J, Yan W. Taurine: a source and application for the relief of visual fatigue. Nutrients. 2023;15:1843.","journal-title":"Nutrients."},{"key":"1344_CR28","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1016\/j.cell.2024.03.011","volume":"187","author":"T Cao","year":"2024","unstructured":"Cao T, Zhang W, Wang Q, Wang C, Ma W, Zhang C, et al. Cancer SLC6A6-mediated taurine uptake transactivates immune checkpoint genes and induces exhaustion in CD8+ T cells. Cell. 2024;187:2288\u2013304.e2227.","journal-title":"Cell."},{"key":"1344_CR29","doi-asserted-by":"publisher","first-page":"648913","DOI":"10.3389\/fimmu.2021.648913","volume":"12","author":"L Meng","year":"2021","unstructured":"Meng L, Lu C, Wu B, Lan C, Mo L, Chen C, Wang X, et al. Taurine antagonizes macrophages M1 polarization by mitophagy-glycolysis switch blockage via dragging SAM-PP2Ac transmethylation. Front Immunol. 2021;12:648913.","journal-title":"Front Immunol"},{"key":"1344_CR30","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s42255-023-00761-7","volume":"5","author":"T Doke","year":"2023","unstructured":"Doke T, Mukherjee S, Mukhi D, Dhillon P, Abedini A, Davis JG, et al. NAD+ precursor supplementation prevents mtRNA\/RIG-I-dependent inflammation during kidney injury. Nat Metab. 2023;5:414\u201330.","journal-title":"Nat Metab"},{"key":"1344_CR31","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/s41577-022-00760-x","volume":"23","author":"S Marchi","year":"2023","unstructured":"Marchi S, Guilbaud E, Tait SWG, Yamazaki T, Galluzzi L. Mitochondrial control of inflammation. Nat Rev Immunol. 2023;23:159\u201373.","journal-title":"Nat Rev Immunol"},{"key":"1344_CR32","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/s41586-023-05720-6","volume":"615","author":"A Hooftman","year":"2023","unstructured":"Hooftman A, Peace CG, Ryan DG, Day EA, Yang M, McGettrick AF, et al. Macrophage fumarate hydratase restrains mtRNA-mediated interferon production. Nature. 2023;615:490\u20138.","journal-title":"Nature."},{"key":"1344_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1403","volume":"13","author":"CG Peace","year":"2023","unstructured":"Peace CG, Hooftman A, Ryan DG. Inflammatory mitochondrial nucleic acids as drivers of pathophysiology. Clin Transl Med. 2023;13:e1403.","journal-title":"Clin Transl Med"},{"key":"1344_CR34","doi-asserted-by":"publisher","first-page":"3174","DOI":"10.3390\/cells11193174","volume":"11","author":"H Hu","year":"2022","unstructured":"Hu H, Guo L, Overholser J, Wang X. Mitochondrial VDAC1: A Potential Therapeutic Target of Inflammation-Related Diseases and Clinical Opportunities. Cells. 2022;11:3174.","journal-title":"Cells."},{"key":"1344_CR35","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1038\/s12276-023-01121-x","volume":"55","author":"J Yoon","year":"2023","unstructured":"Yoon J, Kim S, Lee M, Kim Y. Mitochondrial nucleic acids in innate immunity and beyond. Exp Mol Med. 2023;55:2508\u201318.","journal-title":"Exp Mol Med"},{"key":"1344_CR36","doi-asserted-by":"publisher","first-page":"796066","DOI":"10.3389\/fcell.2022.796066","volume":"10","author":"A Chowdhury","year":"2022","unstructured":"Chowdhury A, Witte S, Aich A. Role of mitochondrial nucleic acid sensing pathways in health and patho-physiology. Front Cell Dev Biol. 2022;10:796066.","journal-title":"Front Cell Dev Biol"},{"key":"1344_CR37","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/s41586-018-0363-0","volume":"560","author":"A Dhir","year":"2018","unstructured":"Dhir A, Dhir S, Borowski LS, Jimenez L, Teitell M, R\u00f6tig A, et al. Mitochondrial double-stranded RNA triggers antiviral signaling in humans. Nature. 2018;560:238\u201342.","journal-title":"Nature."},{"key":"1344_CR38","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s13578-023-01188-z","volume":"13","author":"L Ji","year":"2023","unstructured":"Ji L, Li T, Chen H, Yang Y, Lu E, Liu J, et al. The crucial regulatory role of type I interferon in inflammatory diseases. Cell Biosci. 2023;13:230.","journal-title":"Cell Biosci"},{"key":"1344_CR39","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1093\/jn\/137.8.1887","volume":"137","author":"I Ueki","year":"2007","unstructured":"Ueki I, Stipanuk MH. Enzymes of the taurine biosynthetic pathway are expressed in rat mammary gland1,2. J Nutr. 2007;137:1887\u201394.","journal-title":"J Nutr"},{"key":"1344_CR40","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nri3661","volume":"14","author":"MF Neurath","year":"2014","unstructured":"Neurath MF. Cytokines in inflammatory bowel disease. Nat Rev Immunol. 2014;14:329\u201342.","journal-title":"Nat Rev Immunol"},{"key":"1344_CR41","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/sj.cdd.4401189","volume":"10","author":"H Wajant","year":"2003","unstructured":"Wajant H, Pfizenmaier K, Scheurich P. Tumor necrosis factor signaling. Cell Death Differ. 2003;10:45\u201365.","journal-title":"Cell Death Differ"},{"key":"1344_CR42","doi-asserted-by":"publisher","first-page":"F1000","DOI":"10.12688\/f1000research.17023.1","volume":"8","author":"J Holbrook","year":"2019","unstructured":"Holbrook J, Lara-Reyna S, Jarosz-Griffiths H, McDermott M. Tumour necrosis factor signalling in health and disease. F1000Res. 2019;8:F1000. Faculty Rev-111.","journal-title":"F1000Res"},{"key":"1344_CR43","doi-asserted-by":"publisher","first-page":"103329","DOI":"10.1016\/j.ebiom.2021.103329","volume":"66","author":"G Cui","year":"2021","unstructured":"Cui G, Fan Q, Li Z, Goll R, Florholmen J. Evaluation of anti-TNF therapeutic response in patients with inflammatory bowel disease: current and novel biomarkers. EBioMedicine. 2021;66:103329.","journal-title":"EBioMedicine."},{"key":"1344_CR44","first-page":"13916","volume":"13","author":"LM Genaro","year":"2021","unstructured":"Genaro LM, Gomes LEM, Franceschini APMF, Ceccato HD, de Jesus RN, Lima AP, et al. Anti-TNF therapy and immunogenicity in inflammatory bowel diseases: a translational approach. Am J Transl Res. 2021;13:13916\u201330.","journal-title":"Am J Transl Res"},{"key":"1344_CR45","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.fct.2014.05.023","volume":"71","author":"CA Agca","year":"2014","unstructured":"Agca CA, Tuzcu M, Hayirli A, Sahin K. Taurine ameliorates neuropathy by regulating NF-\u03baB and Nrf2\/HO-1 signaling cascades in diabetic rats. Food Chem Toxicol. 2014;71:116\u201321.","journal-title":"Food Chem Toxicol"},{"key":"1344_CR46","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1523\/JNEUROSCI.3996-07.2008","volume":"28","author":"F Jia","year":"2008","unstructured":"Jia F, Yue M, Chandra D, Keramidas A, Goldstein PA, Homanics GE, et al. Taurine is a potent activator of extrasynaptic GABA(A) receptors in the thalamus. J Neurosci: J Soc Neurosci. 2008;28:106\u201315.","journal-title":"J Neurosci: J Soc Neurosci"},{"key":"1344_CR47","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1080\/14737175.2019.1593827","volume":"19","author":"L Ochoa-de la Paz","year":"2019","unstructured":"Ochoa-de la Paz L, Zenteno E, Gulias-Ca\u00f1izo R, Quiroz-Mercado H. Taurine and GABA neurotransmitter receptors, a relationship with therapeutic potential? Expert Rev Neurother. 2019;19:289\u201391.","journal-title":"Expert Rev Neurother"},{"key":"1344_CR48","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.neuropharm.2006.05.023","volume":"51","author":"M Carta","year":"2006","unstructured":"Carta M, Murru L, Botta P, Talani G, Sechi G, De Riu P, et al. The muscle relaxant thiocolchicoside is an antagonist of GABAA receptor function in the central nervous system. Neuropharmacology. 2006;51:805\u201315.","journal-title":"Neuropharmacology."},{"key":"1344_CR49","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1126\/science.1093616","volume":"303","author":"SS Diebold","year":"2004","unstructured":"Diebold SS, Kaisho T, Hemmi H, Akira S, Reis e Sousa C. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science. 2004;303:1529\u201331.","journal-title":"Science."},{"key":"1344_CR50","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1016\/j.jmb.2019.02.001","volume":"431","author":"MH Wong","year":"2019","unstructured":"Wong MH, Samal AB, Lee M, Vlach J, Novikov N, Niedziela-Majka A, et al. The KN-93 molecule inhibits calcium\/calmodulin-dependent protein kinase II (CaMKII) activity by binding to Ca(2+)\/CaM. J Mol Biol. 2019;431:1440\u201359.","journal-title":"J Mol Biol"},{"key":"1344_CR51","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.3390\/nu16111593","volume":"16","author":"R Frascatani","year":"2024","unstructured":"Frascatani R, Mattogno A, Iannucci A, Marafini I, Monteleone G. Reduced taurine serum levels in inflammatory bowel disease. Nutrients. 2024;16:1593.","journal-title":"Nutrients."},{"key":"1344_CR52","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/cmi.2015.65","volume":"12","author":"B Li","year":"2015","unstructured":"Li B, Zheng SG. How regulatory T cells sense and adapt to inflammation. Cell Mol Immunol. 2015;12:519\u201320.","journal-title":"Cell Mol Immunol"},{"key":"1344_CR53","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.canlet.2012.08.018","volume":"328","author":"E Fagiani","year":"2013","unstructured":"Fagiani E, Christofori G. Angiopoietins in angiogenesis. Cancer Lett. 2013;328:18\u201326.","journal-title":"Cancer Lett"},{"key":"1344_CR54","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/s41392-023-01460-1","volume":"8","author":"Z-L Liu","year":"2023","unstructured":"Liu Z-L, Chen H-H, Zheng L-L, Sun L-P, Shi L. Angiogenic signaling pathways and anti-angiogenic therapy for cancer. Signal Transduct Target Ther. 2023;8:198.","journal-title":"Signal Transduct Target Ther"},{"key":"1344_CR55","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1038\/s42255-024-01145-1","volume":"6","author":"SM O\u2019Carroll","year":"2024","unstructured":"O\u2019Carroll SM, Peace CG, Toller-Kawahisa JE, Min Y, Hooftman A, Charki S, et al. Itaconate drives mtRNA-mediated type I interferon production through inhibition of succinate dehydrogenase. Nat Metab. 2024;6:2060\u201369.","journal-title":"Nat Metab"}],"container-title":["Cellular &amp; Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41423-025-01344-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41423-025-01344-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41423-025-01344-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T23:02:10Z","timestamp":1761865330000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41423-025-01344-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,8]]},"references-count":55,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["1344"],"URL":"https:\/\/doi.org\/10.1038\/s41423-025-01344-0","relation":{},"ISSN":["2042-0226"],"issn-type":[{"value":"2042-0226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,8]]},"assertion":[{"value":"21 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}